ResearcherOregon Health & Science UniversityNo recent work listed
Philip R. Streeter
Matched on OpenAlex author ID A5110247913. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2012: 1 paper · 2013: 1 paper
Papers 2
- Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia. Last author DOI 10.1002/cncy.21223↗
- The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. Last author DOI 10.1016/j.humpath.2011.11.012↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brett C. Sheppard · 2 shared papers, 2012–2013 · strength 0.07
- Paper Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia. DOI 10.1002/cncy.21223↗
- Paper The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. DOI 10.1016/j.humpath.2011.11.012↗
- Terry K. Morgan · 2 shared papers, 2012–2013 · strength 0.07
- Paper Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia. DOI 10.1002/cncy.21223↗
- Paper The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. DOI 10.1016/j.humpath.2011.11.012↗
- Jody E. Hooper · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.